Abstract
Background
With rising worldwide population aging, the number of homebound individuals with multimorbidity is increasing. Improvement in the quality of home medical care (HMC), including medications, contributes to meeting older adults’ preference for “aging in place” and securing healthcare resources.
Objective
To evaluate the changes in drug prescriptions, particularly potentially inappropriate medications (PIMs), among older adults receiving HMC in recent years, during which measures addressing inappropriate polypharmacy were implemented, including the introduction of clinical practice guidelines and medical fees for deprescribing.
Design
A cross-sectional study.
Participants
Using data from the national claims database in Japan, this study included older adults aged ≥ 75 years who received HMC in October 2015 (N = 499,850) and October 2019 (N = 657,051).
Main Measures
Number of drugs, prevalence of polypharmacy (≥ 5 regular drugs), major drug categories/classes, and PIMs according to Japanese guidelines were analyzed. Random effects logistic regression models were used to evaluate the differences in medications between 2015 and 2019, considering the correlation within individuals who contributed to the analysis in both years.
Key Results
The number of drugs remained unchanged from 2015 to 2019 (median: 6; interquartile range: 4, 9). The prevalence of polypharmacy also remained unchanged at 70.0% in both years (P = 0.93). However, the prescription of some drugs (e.g., direct oral anticoagulants, new types of hypnotics, acetaminophen, proton pump inhibitors, and β-blockers) increased, whereas others (e.g., warfarin, vasodilators, H2 blockers, acetylcholinesterase inhibitors, and benzodiazepines) decreased. Among the frequently prescribed PIMs, benzodiazepines/Z-drugs (25.6% in 2015 to 21.1% in 2019; adjusted odds ratio: 0.52) and H2 blockers (11.2 to 7.3%; 0.45) decreased, whereas diuretics (23.8 to 23.6%; 0.90) and antipsychotics (9.7 to 10.5%; 1.11) remained unchanged.
Conclusions
We observed some favorable changes but identified some continuous and new challenges. This study suggests that continued attention to medication optimization is required to achieve safe and effective HMC.
Similar content being viewed by others
Data Availability
The datasets generated and/or analyzed during the current study are not publicly available because data extracted from the NDB is not permitted to use except for those who are authorized.
References
Ornstein KA, Garrido MM, Bollens-Lund E, et al. Estimation of the Incident Homebound Population in the US Among Older Medicare Beneficiaries, 2012 to 2018. JAMA Intern Med. 2020;180(7):1022-1025. doi: https://doi.org/10.1001/jamainternmed.2020.1636
Lapointe-Shaw L, Jones A, Ivers NM, et al. Homebound Status Among Older Adult Home Care Recipients in Ontario, Canada. J Am Geriatr Soc. 2022;70(2):568-578. doi: https://doi.org/10.1111/jgs.17501.
Qiu WQ, Dean M, Liu T, et al. Physical and Mental Health of Homebound Older Adults: an Overlooked Population. J Am Geriatr Soc. 2010;58(12):2423-2428. doi: https://doi.org/10.1111/j.1532-5415.2010.03161.x.
Iwata H, Matsushima M, Watanabe T, et al. The Need for Home Care Physicians in Japan – 2020 to 2060. BMC Health Serv Res. 2020;20(1):752. doi: https://doi.org/10.1186/s12913-020-05635-2.
Arai H, Ouchi Y, Toba K, et al. Japan as the Front-Runner of Super-Aged Societies: Perspectives from Medicine and Medical Care in Japan. Geriatr Gerontol Int. 2015;15(6):673-687. doi: https://doi.org/10.1111/ggi.12450.
Medicare. Home health services. https://www.medicare.gov/coverage/home-health-services. Accessed 20 Jul 2023.
McNabney MK, Fitzgerald P MSc, Pedulla J, Phifer M, Nash M, Kinosian B. The Program of All-Inclusive Care for the Elderly: an Update after 25 Years of Permanent Provider Status. J Am Med Dir Assoc. 2022;23(12):1893-1899. doi: https://doi.org/10.1016/j.jamda.2022.09.004.
Harrison MJ, Dusheiko M, Sutton M, Gravelle H, Doran T, Roland M. Effect of a National Primary Care Pay for Performance Scheme on Emergency Hospital Admissions for Ambulatory Care Sensitive Conditions: Controlled Longitudinal Study. BMJ. 2014;349:g6423. doi: https://doi.org/10.1136/bmj.g6423.
Masumoto S, Sato M, Yamakawa T, et al. Evaluation of Changes in Prescription Among Japanese Elderly Patients Before and After Transition to Home Care. J Gen Fam Med. 2021;23(2):94-100. doi: https://doi.org/10.1002/jgf2.506.
Lee JJ, Hu HY, Lin SY, Huang CM, Huang SJ, Huang N. Factors Associated with Having Home Care Physicians as an Integrated Source of Medications for Chronic Conditions Among Homebound Patients. Int J Qual Health Care. 2022;34(3):mzac055. doi: https://doi.org/10.1093/intqhc/mzac055.
Ishizaki T, Mitsutake S, Hamada S, et al. Drug Prescription Patterns and Factors Associated with Polypharmacy in >1 Million Older Adults in Tokyo. Geriatr Gerontol Int. 2020;20(4):304-311. doi: https://doi.org/10.1111/ggi.13880.
Meyer-Massetti C, Meier CR, Guglielmo BJ. The Scope of Drug-Related Problems in the Home Care Setting. Int J Clin Pharm. 2018;40(2):325-334. doi: https://doi.org/10.1007/s11096-017-0581-9.
Meredith S, Feldman PH, Frey D, et al. Possible Medication Errors in Home Healthcare Patients. J Am Geriatr Soc. 2001;49(6):719-724. doi: https://doi.org/10.1046/j.1532-5415.2001.49147.x.
Cannon KT, Choi MM, Zuniga MA. Potentially Inappropriate Medication Use in Elderly Patients Receiving Home Health Care: a Retrospective Data Analysis. Am J Geriatr Pharmacother. 2006;4(2):134-143. doi: https://doi.org/10.1016/j.amjopharm.2006.06.010.
Lohman MC, Scherer EA, Whiteman KL, Greenberg RL, Bruce ML. Factors Associated with Accelerated Hospitalization and Re-hospitalization Among Medicare Home Health Patients. J Gerontol A Biol Sci Med Sci. 2018;73(9):1280-1286. doi: https://doi.org/10.1093/gerona/glw335.
Golden AG, Preston RA, Barnett SD, Llorente M, Hamdan K, Silverman MA. Inappropriate Medication Prescribing in Homebound Older Adults. J Am Geriatr Soc. 1999;47(8):948-953. doi: https://doi.org/10.1111/j.1532-5415.1999.tb01289.x.
Fialová D, Topinková E, Gambassi G, et al. Potentially Inappropriate Medication Use Among Elderly Home Care Patients in Europe. JAMA. 2005;293(11):1348-1358. doi: https://doi.org/10.1001/jama.293.11.1348.
Bao Y, Shao H, Bishop TF, Schackman BR, Bruce ML. Inappropriate Medication in a National Sample of US Elderly Patients Receiving Home Health Care. J Gen Intern Med. 2012;27(3):304-310. doi: https://doi.org/10.1007/s11606-011-1905-4.
Lohman MC, Cotton BP, Zagaria AB, et al. Hospitalization Risk and Potentially Inappropriate Medications Among Medicare Home Health Nursing Patients. J Gen Intern Med. 2017;32(12):1301-1308. doi: https://doi.org/10.1007/s11606-017-4157-0.
Onda M, Imai H, Takada Y, Fujii S, Shono T, Nanaumi Y. Identification and Prevalence of Adverse Drug Events Caused by Potentially Inappropriate Medication in Homebound Elderly Patients: a Retrospective Study Using a Nationwide Survey in Japan. BMJ Open. 2015;5(8):e007581. doi: https://doi.org/10.1136/bmjopen-2015-007581.
Huang CH, Umegaki H, Watanabe Y, et al. Potentially Inappropriate Medications According to STOPP-J Criteria and Risks of Hospitalization and Mortality in Elderly Patients Receiving Home-Based Medical Services. PLOS ONE. 2019;14(2):e0211947. doi: https://doi.org/10.1371/journal.pone.0211947.
Onda M, Imai H, Shono T, et al. Adverse Drug Reactions Associated to Medications for Homebound Patients: Observations Based on a Nationwide Survey in Japan. Japanese Journal of Pharmacoepidemiology/Yakuzai ekigaku. 2016;21(1):1-11. (in Japanese). doi: https://doi.org/10.3820/jjpe.21.1
Hamano J, Tokuda Y. Inappropriate Prescribing Among Elderly Home Care Patients in Japan: Prevalence and Risk Factors. J Prim Care Community Health. 2014;5(2):90-96. doi: https://doi.org/10.1177/2150131913518346.
Hamano J, Ozone S, Tokuda Y. A Comparison of Estimated Drug Costs of Potentially Inappropriate Medications Between Older Patients Receiving Nurse Home Visit Services and Patients Receiving Pharmacist Home Visit Services: a Cross-Sectional and Propensity Score Analysis. BMC Health Serv Res. 2015;15:73. doi: https://doi.org/10.1186/s12913-015-0732-4.
Kidana K, Ishii S, Osawa I, et al. Medication Prescription in Older People Receiving Home Medical Care Services. Geriatr Gerontol Int. 2019;19(12):1292-1293. doi: https://doi.org/10.1111/ggi.13793.
Kojima T, Mizukami K, Tomita N, et al. Screening Tool for Older Persons’ Appropriate Prescriptions for Japanese: Report of the Japan Geriatrics Society Working Group on “Guidelines for Medical Treatment and Its Safety in the Elderly”. Geriatr Gerontol Int. 2016;16(9):983-1001. doi: https://doi.org/10.1111/ggi.12890.
American Geriatrics Society 2012 Beers Criteria Update Expert Panel. American Geriatrics Society updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults. J Am Geriatr Soc. 2012;60(4):616-631. doi: https://doi.org/10.1111/j.1532-5415.2012.03923.x.
Gallagher P, Ryan C, Byrne S, Kennedy J, O’Mahony D. STOPP (Screening Tool of Older Person’s Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus Validation. Int J Clin Pharmacol Ther. 2008;46(2):72-83. doi: https://doi.org/10.5414/cpp46072.
Ministry of Health, Labour and Welfare. Guidance on appropriate medication for elderly patients. https://www.pmda.go.jp/files/000232249.pdf. Accessed 20 Jul 2023.
Hattori Y, Hamada S, Yamanaka T, et al. Drug Prescribing Changes in the Last Year of Life Among Homebound Older Adults: National Retrospective Cohort Study. BMJ Support Palliat Care. 2022:bmjspcare-2022-003639. doi: https://doi.org/10.1136/spcare-2022-003639.
Yasunaga H. Real word data in Japan: chapter I. NDB. Annals of Clinical Epidemiology. 2019;1(2):28-30.
Hovstadius B, Hovstadius K, Astrand B, Petersson G. Increasing Polypharmacy- an Individual-Based Study of the Swedish Population 2005-2008. BMC Clin Pharmacol. 2010; 10: 16. doi: https://doi.org/10.1186/1472-6904-10-16.
Motter FR, Fritzen JS, Hilmer SN, Paniz ÉV, Paniz VMV. Potentially Inappropriate Medication in the Elderly: a Systematic Review of Validated Explicit Criteria. Eur J Clin Pharmacol. 2018;74(6):679-700. doi: https://doi.org/10.1007/s00228-018-2446-0.
Okui T, Park J, Hirata A, Nakashima N. Trends in the Prescription of Benzodiazepine Receptor Agonists from 2009 to 2020: a Retrospective Study Using Electronic Healthcare Record Data of a University Hospital in Japan. Healthcare (Basel). 2021;9(12):1724. doi: https://doi.org/10.3390/healthcare9121724.
Gosselin E, Simard M, Lunghi C, Sirois C. Trends in Benzodiazepine and Alternative Hypnotic Use in Relation with Multimorbidity Among Older Adults in Quebec, Canada. Pharmacoepidemiol Drug Saf. 2022;31(3):322-333. doi: https://doi.org/10.1002/pds.5383.
Schoenfeld AJ, Grady D. Adverse Effects Associated with Proton Pump Inhibitors. JAMA Intern Med. 2016;176(2):172-174. doi: https://doi.org/10.1001/jamainternmed.2015.7927.
Tampi RR, Tampi DJ, Balachandran S, Srinivasan S. Antipsychotic Use in Dementia: a Systematic Review of Benefits and Risks from Meta-analyses. Ther Adv Chronic Dis. 2016;7(5):229-245. doi: https://doi.org/10.1177/2040622316658463.
Van Leeuwen E, Petrovic M, van Driel ML, et al. Withdrawal Versus Continuation of Long-Term Antipsychotic Drug Use for Behavioural and Psychological Symptoms in Older People with Dementia. Cochrane Database Syst Rev. 2018;3(3):CD007726. doi: https://doi.org/10.1002/14651858.CD007726.pub3.
Grossberg GT, Tong G, Burke AD, Tariot PN. Present Algorithms and Future Treatments for Alzheimer’s Disease. J Alzheimers Dis. 2019;67(4):1157-1171. doi: https://doi.org/10.3233/JAD-180903.
Yamana H, Konishi T, Yasunaga H. Validation Studies of Japanese Administrative Health Care Data: a Scoping Review. Pharmacoepidemiol Drug Saf. 2023 May 5. doi: https://doi.org/10.1002/pds.5636.
Funding
This work was supported by the JSPS KAKENHI (grant numbers 20K18868 and 22K10406). The funding source had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
Author information
Authors and Affiliations
Contributions
SH contributed to the study concept and design, acquisition of data, analysis and interpretation of data, and drafting of the manuscript. SH is responsible for the content as a guarantor. The other authors contributed to the study concept and design, interpretation of data, and critical revision of the manuscript for important intellectual content.
Corresponding author
Ethics declarations
Conflict of Interest
SH, KK, and TY belong to an endowed chair funded by donations from Mr. Kazuteru Noguchi, JSH, Towa Pharmaceutical, Sawai Pharmaceutical, and Ain Pharmaciez. SH received research funding from SOMPO Care Inc. outside of this work. NT received research funding from SMS and FAST DOCTOR. MA received remuneration from Astellas Pharma, Boehringer Ingelheim, Daiichi Sankyo, Eisai, Eli Lilly Japan, Mitsubishi-Tanabe Pharma, Mochida Pharmaceutical, MSD, Ono Pharmaceutical, Pfizer Japan, Sumitomo Dainippon Pharma, and Takeda Pharmaceutical, and received research funding from Astellas Pharma, AstraZeneca, Bayer Health Care, Boehringer Ingelheim, Chugai Pharmaceutical, Daiichi Sankyo, Eli Lilly Japan, Kowa Pharmaceutical, Mitsubishi-Tanabe Pharma, Mochida Pharmaceutical, MSD, Ono Pharmaceutical, Otsuka Pharmaceutical, Pfizer Japan, Taisho Toyama Pharmaceutical, Takeda Pharmaceutical, and Tsumura. The other authors have no conflicts of interest to declare.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Prior presentations: The results of this study were presented at the 5th Annual Meeting of the Japanese Association for Home Care Medicine in Niigata, Japan, on June 24th, 2023.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Hamada, S., Iwagami, M., Sakata, N. et al. Changes in Polypharmacy and Potentially Inappropriate Medications in Homebound Older Adults in Japan, 2015–2019: a Nationwide Study. J GEN INTERN MED 38, 3517–3525 (2023). https://doi.org/10.1007/s11606-023-08364-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11606-023-08364-4